Eraxis 100 mg Powder for solution for infusion
PDF Leaflet Revision Date: 07 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of invasive candidiasis, including candidaemia.
Dosage (summary)
200 mg loading dose on Day 1, followed by 100 mg daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy and breastfeeding; safety not established.
Key Drug Interactions
- Ciclosporin
- Voriconazole
- Tacrolimus
- Liposomal amphotericin B
- Rifampicin
Contraindications
- Hypersensitivity to anidulafungin
- Hypersensitivity to echinocandins
Common side effects
- Rash
- Pruritus
- Hypotension
- Diarrhoea
- Headache
Counselling Points
- Monitor for infusion reactions
- Use effective contraception during treatment
- Avoid in patients with hereditary fructose intolerance
Serious warnings
- Anaphylactic reactions
- Infusion-related reactions
- Hepatic effects
Important Disclaimer
The Eraxis 100 mg Powder for solution for infusion professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
